Cancer - Breast Related News
Silencing a deadly conversation in breast cancer
MEDIA RELEASE:
02 Jun 2011
Garvan researchers have shown that a molecule known as ‘hedgehog’ sits at the centre of a cellular 'switchboard' in breast cancer, transmitting biochemical signals between the cancer cells and the healthy cells nearby. They have identified a new way of turning off this cellular cross talk - which would otherwise allow the cancer to thrive. This off switch offers a potential therapeutic, especially for women with cancers that do not respond to current treatments.
$3.7 million to push cancer discoveries down the ‘pipeline’
14 Oct 2010
The Cancer Institute NSW has awarded the Garvan Institute’s Cancer Research Program $3.7 million, research funding that should lead to improved clinical decision-making for breast, prostate and pancreatic cancer within the next 5 years.
Taking the fingerprint of basal breast cancer
MEDIA RELEASE:
29 Sep 2010
Australian researchers have used sophisticated new protein screening technology to profile basal breast cancer, a particularly aggressive sub-type of breast cancer, identifying specific targets for future treatments.
Falko Hochgräfe wins proteomics award
29 Sep 2010
Dr Falko Hochgräfe, postdoctoral researcher at Garvan, was awarded the Human Proteome Organisation (HUPO) Young Guns Early Career Research Award last week. Fifteen of the field’s brightest young researchers were shortlisted from around the world to present their findings at HUPO’s 9th Annual World Congress held in Sydney.
A step towards finding the cancer switch
MEDIA RELEASE:
17 Jun 2009
Garvan epigeneticists describe exactly what happens to a person's DNA the moment at which a breast cancer suppressor gene is switched off - taking us one step closer towards finding ways to control the biochemical processes that 'switch on' bad genes and 'switch off' good ones.
Nuns on the Run from Dubbo to Darlinghurst for Cancer
MEDIA RELEASE:
19 Apr 2009
Led by two Sisters of Charity, The Nuns’ Run will cover the 400 km distance from Dubbo to Darlinghurst in an effort to raise cancer awareness and crucial funds for the establishment of a new $100 million Cancer Centre within the St Vincent’s Research Precinct, Sydney. Embarking on their journey on 24 May, Sisters Helen Clarke and Leone Wittmack are hoping to arrive in Sydney on 5 June.
Garvan and St Vincent’s to Build $100 million Australian Cancer Centre
MEDIA RELEASE:
22 Oct 2008
The Garvan Institute of Medical Research and St Vincents & Mater Health Sydney will today announce plans to jointly establish a new $100 million Cancer Centre within the St Vincent’s Research Precinct. The Garvan St Vincent’s Campus Cancer Centre (GSVCCC) will integrate internationally acclaimed cancer research with best practice cancer services, enabling research findings to move quickly into patient care.
Calculating how breast cancers will respond to tamoxifen
MEDIA RELEASE:
08 Sep 2008
A discovery by Garvan scientists should help clinicians decide which women with breast cancer will make good candidates for anti-oestrogen therapies, such as tamoxifen, and which will not.
First step towards switching off breast cancer and leukaemia
MEDIA RELEASE:
08 Aug 2008
Garvan scientists have identified a way to ‘switch off’ a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia. The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the target of the drug Herceptin.
Garvan cancer researcher wins Premier's Award
18 Jun 2008
Garvan researcher Rebecca Hinshelwood received the highly coveted $10,000 Premier’s Award for Outstanding Cancer Research Scholar at a gala ceremony last month. The award, from the Cancer Institute of NSW, is a form of educational scholarship.
Targeting aggressive breast cancers by putting them to sleep
MEDIA RELEASE:
25 Mar 2008
Dr Alex Swarbrick, head of Garvan's Tumour Progression Research Group, has published findings that Id1, a gene produced by the most aggressive forms of breast cancer, can control breast cancer growth. He has shown that by 'switching off' the Id1 gene, it is possible to induce a state of 'senescence', or permanent sleep, within a tumour, preventing it from growing or spreading.
The molecule that can switch appetite off and on
05 Nov 2007
Researchers from the St Vincent’s Campus have identified the molecule responsible for the extreme weight loss common in late stage cancer. The findings published online in Nature Medicine suggest it may soon be possible to prevent this condition, giving people the strength to survive treatment. Conversely, the knowledge also suggests a way to switch off appetite in obese people.
Cancer genetics to combine forces with nanotechnology to fight breast cancer
MEDIA RELEASE:
04 Oct 2007
Associate Professor Susan Clark, head of Garvan’s Epigenetics Research Group, will play a leading role in a $5 million national research program called "Nanoscaled epigenetic biosensors: How combining two novel technologies will help Advanced Breast Cancer" announced today by the National Breast Cancer Foundation.
Persin - the avocado toxin that kills breast cancer cells
14 Jun 2007
Researchers in Garvan's cancer program have shown that a compound found in the leaves and fruit of the avocado tree can kill breast cancer cells
Garvan Scientist wins Gustav Nossal Scholarship
30 Mar 2007
Each year the highest ranked applicant for an NHMRC (National Health and Medical Research Council) Medical and Dental Postgraduate Research Scholarship wins the Gustav Nossal Scholarship. This year’s recipient, Dr Sandra Biankin who is using the funds to undertake her PhD at Garvan.
